Clinical Trials Directory

Trials / Unknown

UnknownNCT02571699

Minimum Effective Volume of Lidocaine-Bupivacaine for Subgluteal Block

Minimum Effective Volume of Lidocaine-Bupivacaine for Ultrasound-Guided Subgluteal Sciatic Nerve Block

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block.

Detailed description

The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block. Success rate is defined as a minimal composite score of 6 points (out of 8 points) at 30 minutes.

Conditions

Interventions

TypeNameDescription
OTHERSubgluteal Nerve Blockultrasound-guided subgluteal sciatic nerve block.

Timeline

Start date
2016-03-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-10-08
Last updated
2016-06-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02571699. Inclusion in this directory is not an endorsement.